1. Microbiology of sputum from patients with cystic fibrosis centers in the United States;Burns;Clin Infect Dis,1998
2. Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients;Burns;J Clin Microbiol,2000
3. The changing epidemiology of cystic fibrosis;FitzSimmons;J Pediatr,1993
4. Gilligan, P. H. (1995). Pseudomonas and Burkholderia. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, & R. H. Yolken (Eds.), Manual of Clinical Microbiology (6th ed., p. 509–519). Washington, DC: ASM Press.
5. National Committee for Clinical Laboratory Standards. (2000). Performance standards for antimicrobial disk susceptibility tests, 7th ed. Approved standard M2–A7. National Committee for Clinical Laboratory Standards, Wayne, PA.